Randomized, Double-blind, Crossover, PK and GD Study of CSII in Subjects With Type 1 Diabetes

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by Halozyme Therapeutics.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Halozyme Therapeutics
ClinicalTrials.gov Identifier:
NCT01275131
First received: January 10, 2011
Last updated: March 6, 2012
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2012
  Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)